Zileuton (Compound)

Synonyms:ZILEUTON, 111406-87-2, Zyflo, Leutrol, 1-(1-(Benzo[b]thiophen-2-yl)ethyl)-1-hydroxyurea, Zileutonum, Abbott 64077, Zileutonum [INN-Latin], 1-[1-(1-benzothiophen-2-yl)ethyl]-1-hydroxyurea, N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea, A 64077, A-64077, Zyflo (TN), ABBOTT-64077, Urea, N-(1-benzo[b]thien-2-ylethyl)-N-hydroxy-, CHEMBL93, 1-[1-(1-benzothien-2-yl)ethyl]-1-hydroxyurea, N-[1-(benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea, (+-)-1-(1-Benzo(b)thien-2-ylethyl)-1-hydroxyurea, (+/-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea, Zyflo CR, CHEBI:10112, n-(1-benzo[b]thien-2-ylethyl)-n-hydroxyurea, (+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea, MFCD00866097, NCGC00159453-02, DSSTox_CID_3752, DSSTox_RID_77185, DSSTox_GSID_23752, Urea, N-(1-benzo(b)thien-2-ylethyl)-N-hydroxy-, N-(1-BENZO(B)THIEN-2-YL-ETHYL)-N-HYDROXYUREA, Ziluton, Zyflo Filmtab, ( inverted exclamation markA)-1(1-Benzo[b]thien-2-ylethyl)-1-hydroxyure, SMR000466377, CAS-111406-87-2, Zileuton (USP/INN), SR-01000759349, CTI-02, ABT-077, Zileuton [USAN:USP:INN:BAN], Zileuton- Bio-X, Prestwick0_001090, SCHEMBL4209, MLS000759510, MLS001424079, MLS006011971, GTPL5297, Zileuton, >=98% (HPLC), DTXSID9023752, SCHEMBL18251470, Urea, N-(1-benzo(b)thien-2-ylethyl)-N-hydroxy-, (+-)-, HMS2051M20, HMS2089J12, HMS2093H06, HMS2235O04, HMS3369I17, HMS3393M20, HMS3654J08, HMS3714E07, HMS3872F13, Pharmakon1600-01505906, AMY12540, BCP16199, Tox21_111680, Tox21_301148, BBL029070, BDBM50000541, NSC730712, NSC759277, s1443, STL373010, AKOS000280127, AKOS016340558, Tox21_111680_1, CCG-100901, CCG-213571, CS-1563, DB00744, KS-1195, MCULE-7670046922, NC00151, NSC 730712, NSC 759277, NSC-730712, NSC-759277, SB19083, MRF-0000030, NCGC00159453-03, NCGC00159453-04, NCGC00159453-05, NCGC00159453-06, NCGC00255046-01, AC-13198, AC-31490, BZ164573, HY-14164, SBI-0206869.P001, AB0012645, DB-015071

Pubchem:PUBCHEM:60490

Id:60490

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Zileuton's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Zileuton.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Zileuton.

Results found

Linked to

	Label	Description
	BRD-A56359832-001-04-6 Substance (Entity type)	A Substance
	zileuton (c5569ab5-f8d3-41c6-b3a4-3fbec1b2b25d) Collection (Entity type)	Metadatata for zileuton
	DCSTRUCT ID 02862 Collection (Entity type)	DrugPage Collection: (DrugCentralID:02862; PubChem_CID:60490, FILE=drugcentral_drug_02862.json)
	Zileuton positively regulates SPRED2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Zileuton positively regulates BEX1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Zileuton in similarity relationship with Prima-1-met Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Zileuton positively regulates OLFML3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Zileuton negatively regulates XIST Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Zileuton indication Allergic asthma Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Zileuton positively regulates CA2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS